期刊文献+

基因多态性与华法林剂量关系的研究 被引量:1

Research progress of relation between gene polymorphism and warfarin dose
原文传递
导出
摘要 华法林被临床广泛应用于血栓栓塞性疾病的治疗和预防,如何安全有效地应用华法林已成为研究热点。研究发现华法林的量效关系受多种因素影响,其中以基因多态性对个体差异的影响较为突出,现从华法林代谢途径和作用机制两方面阐述基因多态性对华法林剂量个体差异的影响。 Warfarin is the most commonly used oral anticoagulant worldwide for the prevention and treatment of thromboembolic disease. How to use warfarin safely and effectively has become a research topic. The researches have found that the anticoagulant effect of warfarin is affected by many factors, especially gene polymorphism. This article diseusses the influence of gene polymorphism on interindividual variability of warfarin from two aspects of warfarin metabolic pathway and pharmacological mechanism.
出处 《国际呼吸杂志》 2015年第22期1756-1760,共5页 International Journal of Respiration
基金 河北省卫生厅科研基金项目(2013)
关键词 华法林剂量 基因多态性 个体差异 Warfarin dose Gene polymorphism Inter-individual variability
  • 相关文献

参考文献37

  • 1Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9thed.. American College of Chest Physicians Evidence-Baaed Clinical Practice Guidelines[J]. Chest,2012,141 (2Suppl) : e152S-184S.
  • 2Johnson JA, Gong L, Whirl-Carrillo M, et al. Clinal Pharmacogenetics Implementation consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing[J]. Clin Pharmacol Ther,2011,90(4) : 625-629.
  • 3DrAndrea G, D' Ambrosio RL, Di Perna P, et al. A polymorphism in the VKORCI gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin[J]. Blood, 2005,105 (2) : 645-649.
  • 4Rost S,Fregin A,Ivaskevicius V,et al. Mutations in VKORCI cause wafarin resistance and multiple coagulation factor deficiency type2[J]. Nature, 2004,427(6974) : 537-541.
  • 5Bodin L, Verstuyft C, Tregouet DA, et al. Cytochrome P450 2C9(CYP 2C9) and vitamin K epoxide reductase (VKORC1) genotypes as deter:minants of acenocoumarol sensitivity[J]. Blood,2005,106(1) :135-140.
  • 6章伟平,陈慧,骆杰伟,吴小盈.CYP2C9 1061 A/C与VKORC1-1639 G/A基因多态性对华法林应用剂量的影响[J].医学分子生物学杂志,2007,4(5):396-400. 被引量:8
  • 7Yuan HY, Chen JJ, Lee MT, et al. A novel functional VKORCI promoter polymorphism is associated with inter- individual and inter-ethnic differences in warfarin sensitivity [J]. Hum Mol Genet,2005,14(13):1745-1751.
  • 8Veensra DL, You JH, Rieder MJ, et al. Association of Vitamin K epoxi-de reductase complexl (VKORC1) variants with warfarin dose in Hong Kong patient population[J]. Pharmacogenetic Genomics,2005,15(10):687-691.
  • 9唐雪峰,张微,张伟娟,孔繁翠,祝锦,王鹤尧,郑文婕,王辰.VKORC1基因多态性对汉族静脉血栓栓塞患者服用华法林剂量的影响[J].临床药物治疗杂志,2009,7(3):42-50. 被引量:3
  • 10Mannucei PM, Spreafieo M, Peyvandi F, et al. Dosing anticoagulant therapy with eoumarin drugs: is genotyping elinicaiIy useful? No [J]. J Thromh Haemost, 2008,6 (9) :1450-1452.

二级参考文献56

  • 1Hirsh J,Dalen JE,Anderson DR,et al.Oral anticoagulants:mechanism of action.clinical effectiveness,and optimal therapeutic range.Chest,1998,114:445S-469S
  • 2Hylek EM,Skates SJ,Shechan MA,et al.An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrilhfion.N Engl J Med,1996,124:970-979
  • 3Wadetius M and Pirmohamed M.Pharmacogenetics of warfarin:current status and future challenges.Pharmacogenomics J,2006,7:99-111
  • 4YUAN HY,CHEN JJ,LEE MT,et al.A uovel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differcence in warfarin sensitivity.Hum Mol Genet,2005,14(13):1745-1751
  • 5Boom R,Sol C J A,Salimans M M,et al.Rapid and simple method for purification of nucleic acids.J Clin Microbial,1990,28(3):495-503
  • 6Krausa P,Bodmer JG,Browing MJ,et al.Defining the common subtypes of HLA-A9,A10,A28,and A19 by use of ARMS/PCR.Tissue antigens,1993,42:91-95
  • 7Wang T L,Li H L,Tjong W Y,et al.Genetic factors contribute to patient-specific warfarin dose for Hart Chinese.Clinica Chimica Acts,2008,396:76-79
  • 8Lee SC,Ng SS,Oldenburg J,et al.Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population.Clin Pharmacol Ther,2006,79(3):197-205
  • 9D'ANDREA G,D'AMBROSIO RL,D I PERNA P,et al.A polymorphism in the VKORC1 gene is associated with an inter individual variability in the dose anticoagulant effect of warfarin.Blood,2005,105(2):6d5-649
  • 10Lacut K,Larramendy-Gozalo C,Le Gal G,et al.Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism:results from the EDITH Study.J Thmmb Haemost,2007,5:2020-2024

共引文献28

同被引文献2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部